Headlands Technologies »

Heron Therapeutics shares owned by Headlands Technologies

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $30k 11k 2.77
2023-06-30 $3.1k 2.6k 1.16

More positions owned by Headlands Technologies

NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Linde SHS (LIN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vale S A Sponsored Ads (VALE)
Asml Holding N V N Y Registry Shs (ASML)
Rio Tinto Sponsored Adr (RIO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Applied Materials (AMAT)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Broadcom (AVGO)
At&t (T)
Verisign (VRSN)

View all positions for Headlands Technologies

Top funds holding Heron Therapeutics

Rubric Capital Management
OrbiMed Advisors
Vanguard Group
BlackRock
Velan Capital Investment Management
Franklin Resources
Tejara Capital
Palisade Capital Management
Millennium Management
Adage Capital Partners GP
Geode Capital Management
Clearline Capital
D. E. Shaw & Co
State Street Corporation
Renaissance Technologies

View all funds holding Heron Therapeutics